Premium
Tumor‐Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti‐FGF23 Monoclonal Antibody
Author(s) -
Whyte Michael P
Publication year - 2021
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.4280
Subject(s) - osteomalacia , monoclonal antibody , medicine , antibody , monoclonal , cancer research , immunology , osteoporosis